These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32043759)

  • 1. Effect of monoterpenes on ex vivo transungual delivery of itraconazole for the management of onychomycosis.
    Abdollahi D; Jafariazar Z; Afshar M
    J Cosmet Dermatol; 2020 Oct; 19(10):2745-2751. PubMed ID: 32043759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation on utility of some novel terpenes on transungual delivery of fluconazole for the management of onychomycosis.
    Adin SN; Gupta I; Ali A; Aqil M; Mujeeb M; Sultana Y
    J Cosmet Dermatol; 2022 Oct; 21(10):5103-5110. PubMed ID: 35390220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
    Pal P; Thakur RS; Ray S; Mazumder B
    Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on Utility of Some Novel Terpenes on Transungual Delivery of Terbinafine for the Management of Onychomycosis.
    Gupta I; Adin SN; Aqil M; Mujeeb M; Sultana Y
    Dermatol Pract Concept; 2022 Nov; 12(4):e2022202. PubMed ID: 36534578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routes of drug delivery into the nail apparatus: Implications for the efficacy of topical nail solutions in onychomycosis.
    Gupta AK; Simpson FC
    J Dermatolog Treat; 2016; 27(1):2-4. PubMed ID: 25983025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized Ciclopirox-Based Eudragit RLPO Nail Lacquer: Effect of Endopeptidase Enzyme as Permeation Enhancer on Transungual Drug Delivery and Efficiency Against Onychomycosis.
    Khattab A; Shalaby S
    AAPS PharmSciTech; 2018 Apr; 19(3):1048-1060. PubMed ID: 29138987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
    Gupta AK
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S81-95. PubMed ID: 11051137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Onychomycosis: therapy directed by morphology and mycology.
    Barber K; Barber J
    Skin Therapy Lett; 2009 Jan; 14(1):1-2. PubMed ID: 19214354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Presence of an Air Gap Between the Nail Plate and Nail Bed in Onychomycosis Patients: Treatment Implications for Topical Therapy.
    Gupta AK; Pillai R
    J Drugs Dermatol; 2015 Aug; 14(8):859-63. PubMed ID: 26267730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
    Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
    Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pharmacokinetic studies of continuous itraconazole for the treatment of onychomycosis.
    Kawada A; Aragane Y; Tezuka T
    J Dermatol; 2004 Feb; 31(2):104-8. PubMed ID: 15160863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and evaluation of microemulsion-based efinaconazole formulations for targeted treatment of onychomycosis through transungual route: Ex vivo and nail clipping studies.
    Agrawal V; Patel R; Patel M; Thanki K; Mishra S
    Colloids Surf B Biointerfaces; 2021 May; 201():111652. PubMed ID: 33740733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary Techniques and Potential Transungual Drug Delivery Nanosystems for The Treatment of Onychomycosis.
    Abd-Elsalam WH; Abouelatta SM
    AAPS PharmSciTech; 2023 Jul; 24(6):150. PubMed ID: 37421509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
    Monti D; Saccomani L; Chetoni P; Burgalassi S; Senesi S; Ghelardi E; Mailland F
    Br J Dermatol; 2010 Feb; 162(2):311-7. PubMed ID: 19886884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis.
    Willemsen M; De Doncker P; Willems J; Woestenborghs R; Van de Velde V; Heykants J; Van Cutsem J; Cauwenbergh G; Roseeuw D
    J Am Acad Dermatol; 1992 May; 26(5 Pt 1):731-5. PubMed ID: 1316389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis.
    Rigopoulos D; Katoulis AC; Ioannides D; Georgala S; Kalogeromitros D; Bolbasis I; Karistinou A; Christofidou E; Polydorou D; Balkou P; Fragouli E; Katsambas AD
    Br J Dermatol; 2003 Jul; 149(1):151-6. PubMed ID: 12890209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.